← Research library

An open clinical trial of cortexin in treatment of brain ischemia

Observational study · 2014

What was studied
Analysis of 500 patients with stage II brain ischemia
Main finding
The authors describe before/after cognitive, affective, and neurological changes in an open treatment analysis.

Reported findings and study design

Open screening program: 50,000 patients in 70 cities; analyzed subgroup 500 with stage-II brain ischemia, mean age 63.7 ± 10.23. Cortexin 10 mg/day for ten days; assessments before treatment and days 11 and 30.

Population or model Analysis of 500 patients with stage II brain ischemia

Dose, route and schedule

Cortexin: 10 mg/day for ten days. The route is not specified in the indexed abstract.

Protocol source ↗ · Indexed publication abstract

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Analyzed treatment sample500The 50,000-person screening program is not the analyzed trial sample
Cognitive/affective and focal symptomsImprovement reportedNo numerical score changes supplied

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • No untreated comparison is described in the abstract.
  • The analysis sample is 500; the larger screening population is not the analyzed sample.
  • This paper did not measure wearable sleep stages and cannot validate the n=1 diary.

Source details

PubMed record and English abstract checked. Open interventional report; grouped here with uncontrolled observational evidence.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

V. V. Mashin, L. A. Belova, O. I. Chaplanova, A. F. Khusnullina, A. M. Manasian. An open clinical trial of cortexin in treatment of brain ischemia Zh Nevrol Psikhiatr Im S S Korsakova. 114(9):49–52

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards